Skip to main content
logo
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
12.13
+0.56 (4.84%)
At close: Aug 19, 2026, 4:00 PM EDT
11.91
-0.22 (-1.82%)
After-hours: Aug 19, 2026, 7:30 PM EDT

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $39.66M in the quarter ending June 30, 2026, with 53.25% growth. This brings the company's revenue in the last twelve months to $136.07M, up 119.40% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth.

Revenue (ttm)
$136.07M
Revenue Growth
+119.40%
P/S Ratio
5.29
Revenue / Employee
$2,230,672
Employees
61
Market Cap
720.33M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025106.47M82.86M350.91%
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Phathom Pharmaceuticals239.66M
Autolus Therapeutics117.39M
Gyre Therapeutics109.82M
Assembly Biosciences74.85M
Crescent Biopharma11.88M
Shattuck Labs1.00M
Revenue Rankings

ZVRA News

More News